Covalent cholesterol conjugates have been prepared by isoxazole-generating [3+2] nitrile oxide alkyne cycloaddition (NOAC) chemistry. Steroidal building blocks functionalised with either an alkyne or a nitrile oxide precursor were evalu-
Introduction
Cholesterol is one of the most common natural lipids, and due to its bioavailability and structural rigidity, functionalised cholesterol building blocks have attracted interest in areas ranging from materials to medicinal chemistry. There have been a number of reports on triazole-mediated conjugation by copper(I)-promoted dipolar cycloaddition using both azido lipids and cholesterol-alkynes. This powerful click chemistry approach [1] has opened access to new cholesterol pharmacophores, [2a,2b] and has allowed the creation of specialist materials, including cholesterol-incorporating organogels, [2c,2d] nanoparticles, [2e] liquid crystals, [2f] and orthopaedic medical devices.
[2g] It has also facilitated access to cholesterol-dye conjugates for biomembrane [2h] or metabolic studies, [2i] to steroidal glycosides, [2j] and to lipid-oligonucleotide conjugates for drug delivery applications. [2k-2m] In addition, catalyst-free routes to triazole-linked cholesterol-oligonucleotide conjugates have been reported. [3] However, aside from exploitation of the masked functionality of the isoxazole nucleus to access polyhydroxylated steroids, cholesterol conjugates with this heterocyclic linker are relatively unknown. Thermally promoted cycloadditions to C-17-anchored steroidal alkynes have yielded important reaction intermediates. [4] In recent years, the regioselectivity of such cycloadditions has been enhanced through the use of copper [5a-5c] or ruthenium catalysis.
[5d] Transient nitrile oxide dipoles have been generated by the action of PhNCO on steroidal nitroalkane precursors, [6] or from C-22 aldoximes by the NCS/NEt 3 protocol. [7] The work described in this paper demonstrates the versatility of nitrile oxide alkyne cycloaddition (NOAC) ated. The reaction has been demonstrated for the tethering to cholesterol of groups capable of bioreporting, and for the formation of cholesterol-biomolecule conjugates.
chemistry [8] for the formation of cholesterol conjugates anchored by way of a polar, aromatic, metabolically stable isoxazole nucleus.
Results and Discussion
To maximize structural diversity, and to avoid potential stereochemical complications, we required the alkyne or nitrile oxide precursors to be anchored to the C-3β oxygen atom rather than directly to the tetracyclic core.
[6b] The Montmorillonite K-10 (MK-10) [9] promoted route to steroidal ethers 1-3 is shown in Scheme 1. The reported procedure for the formation of propargyl ether 1, which requires a solution of cholesterol and the corresponding alcohol in CHCl 3 to be stirred for 7 d at 55°C, [10] was modified so that the product could be obtained with minimal compromise in yield after just 17 h at 90°C in a microwave (MW) reactor. Following the modified procedure, homologous alkynyl ethers 2 and 3 were obtained in 62 and 70 % yields, respectively.
Model NOAC reactions were explored between 1-3 and phenyl nitrile oxide, which was generated in situ from benzaldehyde oxime on exposure to an ethanolic solution of chloramine-T (Ch-T). While there was no evidence for a compromise in regiochemical integrity, the yields of 3,5-disubstituted isoxazoles 4a-6a were greatly influenced by the spacing between the bulky lipid and the reacting alkyne. Thus, compound 6a, with a 4-carbon linker, was obtained in 90 % yield after 1 h at room temperature. Compound 5a, with a shorter ethylene spacer, was obtained in only 44 % after the same reaction time. Significantly, compound 4a, with a methylene spacer, was formed in a mere 19 % yield, even after 17 h. The same reactivity trend was seen with the putative dipoles generated from 1-naphthyl and 1-pyrenyl oximes. Gratifingly, we found that the sluggish reactivity of propargylated steroid 1a could be circumvented by conducting the reaction in a microwave reactor. In this way, the product yields for 4a-4c increased to 78, 96, and 71 %, respectively.
The potential of the NOAC reaction to access biologically relevant cholesterol probes is illustrated by the preparation of steroid-coumarin 7 and steroid-azobenzene 8 conjugates. Cholesterol is implicated in a vast array of biological processes, and fluorescent derivatives are useful tools that can be used for imaging in cells and tissues; [11] azoderivatised molecules are attractive for the construction of thermal and photoresponsive materials, [12a,12b] including phototriggered drug-delivery vehicles.
[12c] Fluorescent coumarin conjugate 7 was formed in 75 % yield by the cycloaddition reaction between 3 and the nitrile oxide generated from coumarin 6-aldoxime.
[13a] Photoresponsive azo-conjugated steroid 8 was obtained by a parallel reaction sequence involving 4-(phenylazo)benzaldehyde oxime [13b] as the dipole precursor (Figure 1 ). Initially obtained almost exclusively as the trans-isomer, 8 was transformed into an 84:16 mixture of trans and cis isomers after exposure to sunlight for 2 h. When the sample was returned to darkness, the original exclusively trans geometry was restored.
To increase the flexibility of the NOAC approach to cholesterol conjugation, steroidal building blocks bearing nitrile oxide precursors were pursued. The reported successes of cholesterol chloroformate as a handle for the introduction of alkyne [14a] or azido [14b] functionalities suggested that it would be an appropriate building block for oxime introduction by way of an amidocarbamate linker. However, after sequential acetal deprotection and oxime formation, as outlined in Scheme 2, the target oxime (i.e., 12) was obtained in just 2 % overall yield, primarily as a result of a low-yielding deprotection step. Fortunately, we discovered that aldehyde regeneration and oximation could be achieved in a one-pot procedure. Thus, direct exposure of acetal 10 to NH 2 OH·HCl in ethanolic pyridine in a microwave reactor (125°C, 1 h, P max 300 W) yielded steroidal oxime 12 in 91 % yield. Putative steroidal nitrile oxide 13, derived from 12 upon treatment with chloramine-T, was trapped with both propargyl alcohol and propargyl phenyl ether, however, the yields of the cholesterol conjugates (i.e., 14a and 14b) were modest (21 and 37 %). The low yields of the cycloadducts may be a consequence of solubility issues arising from a suboptimal balance of hydrophilic and hydrophobic character of the microenvironments of the lipid-amidocarbamate-isoxazole conjugate. Stable longchain hydrophilic linkers are attractive for bioconjugation, and for this reason, amidocarbamate substrates were abandoned in favour of ether-linked analogues 16 (Scheme 3). Regioisomeric steroidal oxime ethers 16 were prepared in two steps, as shown in Scheme 3. MK-10-mediated condensation [9] between cholesterol and the relevant hydroxyethoxybenzaldehyde gave aldehydes 15 in 35-58 % yield after 8 h in a microwave reactor (P max 300 W). As noted for p-15, no significant increase in yield was observed when the reaction time was doubled to 17 h. Oximation proceeded quantitatively, and the latent reactivity of 16 as a nitrile oxide precursor was demonstrated by the formation of cholesterol conjugates 18. Thus, following overnight stirring of an eth- anolic solution of oxime 16 and chloramine-T in the presence of phenyl propargyl ether, 18a-18c were isolated in 29-58 % yield. It is likely that the variation in yield of the o-, m-, and p-substituted isomeric cycloadducts reflects the effect of the bulky steroidal core on the transition state leading to isoxazole formation. Thus, the steric demand is greatest for the alignment leading to o-18, and the yield of the cycloadduct is lowest (29 %); the bulk of the steroidal core has a minimal impact on the transition state leading to p-18, which results in a significantly improved yield of the cycloadduct (58 %). A further improvement in the yield of p-18 to an attractive 80 % was achieved by adding the steroidal oxime and chloramine-T portionwise to a solution of the dipolarophile in ethanol.
Aryl ethers of natural alcohols are inherently interesting both as end products and as intermediates en route to functional materials. Their synthesis is non-trivial and has attracted significant interest. [15] To validate NOAC chemistry as a vehicle for the assembly of cholesterol conjugates like 21, aldehyde-functionalised aryl ether 19 was required. It is known that MK-10-promoted aryl etherification of cholesterol in CHCl 3 at 50-70°C is suited to electron-rich, but not to electron-deficient phenols. [9] However, we are pleased to report that the use of microwave irradiation in the reaction between cholesterol and p-hydroxybenzaldehyde (90°C, 8 h, P max 300 W) resulted in the formation of 19 (62 %). With the key intermediate to hand, subsequent oximation and cycloaddition resulted in the formation of isoxazole-linked aryl cholesterol ether 21 (Scheme 4).
Covalently functionalised cholesterol bioconjugates including sugar-cholesterol, [16a] amphiphilic DNA-cholesterol, [16b] and nucleoside-cholesterol [16c] conjugates have valuable roles as components of model biological membranes, [16d] and as specialist materials for drug-delivery applications. Thus, the potential of NOAC chemistry to deliver cholesterol bioconjugates is an effective marker of its utility. Steroidal glycoconjugate formation is demonstrated by the regioselective formation of 23 (85 %) by the reaction of putative nitrile oxide p-17 with protected d-galactose 22 as a model sugar dipolarophile. [17] The selective tethering of one or two cholesterol units to a thymidine skeleton was demonstrated by trapping of the same dipole by 5Ј-protected mono-or bis-propargylated thymidines 24 or 26 [18] to give conjugates 25 and 27 in 81 and 68 % yields, respectively (Scheme 5). The mono-and bis-steroidal conjugates are potentially useful building blocks for the formation of syn-thetic oligonucleotides with tuneable amphiphilic properties. The structures of all the isoxazole-linked cholesterol conjugates are supported by spectroscopic data. In particular, diagnostic NMR spectral signals consistent with the regiospecific formation of 3,5-disubstituted isoxazoles include a singlet resonance in the region 6.30-6.63 ppm of the 1 H spectrum, characteristic of the 4-H ring proton, [5d] and a resonance in the of the 13 C spectrum in the range 99-104 ppm due to the corresponding carbon atom.
Conclusions
In conclusion, NOAC chemistry has been verified as a straightforward and convenient method for the formation of diverse cholesterol conjugates including those of poten-tial value as biochemical probes. The NOAC tethering method avoids catalysts and optimisation of numerous reagents as well as the potentially problematic task of separating such reagents from the crude reaction products. The reaction is flexible in that either of the two functionalities needed for the [3+2] cycloaddition can be introduced at the 3β position of the steroidal core. This facilitates the introduction of the conjugating partner as either the dipole or the dipolarophile, without incurring any stereochemical penalties. The hydrophobic/hydrophilic balance of the steroidal reactants and products is important for the success of the reaction, as is the length of the linker that separates the rigid cholesterol core from the cycloaddition partner. In a future communication, we will describe the use of NOAC on the solid phase for the synthesis of oligonucleotidecholesterol conjugates.
Experimental Section
General Remarks: Analytical TLC was carried out on precoated (250 mm) silica gel 60 F-254 plates from Merck. Plates were visualized by UV irradiation, and/or staining with H 2 SO 4 (5 % in ethanol) followed by heating. Flash-chromatography-grade silica gel 60 (230-400 mesh) was obtained from Merck. High-resolution mass spectra were recorded with a Bruker BioApex 70 eV spectrometer. IR spectra were recorded on disposable polyethylene cards (19 mm, type 61, 3M) with a Perkin-Elmer Spectrum 100 RX-I series FTIR spectrophotometer. Reactions using microwave (MW) irradiation were carried out with a Discover SP (CEM, Matthews North Carolina, USA) apparatus, with an Explorer, controlled by the Synergy TM software. Melting points were determined with a Stuart Equipment SMP 11 apparatus. NMR spectra were obtained for 1 H at 300 MHz and for 13 C at 75 MHz with a Bruker instrument at 25°C. All samples for NMR spectroscopy were prepared in CDCl 3 . Chemical shifts are reported in ppm downfield from tetramethylsilane, and coupling constants are reported in Hertz. Anhydrous solvents were distilled from calcium chloride, calcium hydride, potassium hydroxide, or sodium as appropriate. Chemical reagents were purchased from Aldrich Chemical Company unless otherwise noted, and were used without further purification.
General Etherification Procedure:
A mixture of cholesterol (500 mg, 1.29 mmol), alkynyl alcohol (6.47 mmol, 5 equiv.), and MK-10 (1.00 g, activated at 120°C overnight before use) in chloroform (5 mL) was heated to 90°C for 17 h in a microwave reactor (10 mL vessel, P max = 300 W). The solvent was removed under reduced pressure, hexane (20 mL) was added, and the catalyst was removed by filtration and then washed with hexane. The filtrate and washings were evaporated, and the residue was purified by flash column chromatography (hexane/EtOAc; 0-5 %) to give the title compounds as white solids.
Method 1:
The oxime (2 equiv.), Ch-T (2.5 equiv.), and EtOH (1 mL per 0.1 mmol oxime) were put into a round-bottomed flask, and alkyne 1, 2, or 3 (1 equiv.) was added. The mixture was stirred at room temp. To overcome solubility issues with pyrene oxime, the mixture was sonicated for 10 min before the reaction. The mixture was stirred for 1 h, then the solvent was removed. The residue was dissolved in chloroform, and this solution was washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed. The crude reaction products were purified by flash column chromatography (hexane/EtOAc 0-5 %).
Method 2 (MW Activation):
The oxime (2 equiv.), Ch-T (2.5 equiv.), and EtOH (3 mL per 0.5 mmol oxime) were put into a 10 mL microwave vessel, and cholesteryl propargyl ether 1 (1 equiv.) was added. The mixture was heated (100°C for 1 h with benzaldehyde oxime; 60°C for 30 min for 1-naphthaldehyde or 1-pyrene oxime) in a microwave reactor (P max = 300 W). The solvent was removed, and the residue was dissolved in chloroform and washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. The crude reaction products were purified by flash column chromatography (hexane/EtOAc 0-5 %).
Method 3:
The oxime (2 equiv.) was put into a round-bottomed flask, and Ch-T (2.5 equiv.) in EtOH (25 % aq.; 1 mL per 0.1 mmol oxime) was added. The resulting solution was allowed to stir for 10 min at room temp., after which the alkyne (1 equiv.) was added. The mixture was stirred for 1 h, then the solvent was removed. The residue was dissolved in chloroform and washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed. The crude reaction products were purified by flash column chromatography (petroleum ether/EtOAc 0-10 %). -5-en-3β-yloxy)-1-butyl]-3-(1-pyrenyl) Cholest-5-en-3βyloxy)-1-butyl]-3-[4-(2-phenyldiazenyl) [19] In a modification of the literature procedure, a solution of cholesterol chloroformate (2.25 g, 5 mmol) in dry toluene (100 mL) was added dropwise over 30 min to a solution of ethylenediamine (16.7 mL, 250 mmol) in dry toluene (150 mL) at 0°C under a nitrogen atmosphere. The resulting solution was stirred at room temperature for 17 h. The reaction mixture was washed with water, the organic extract was dried with anhydrous magnesium sulfate, and the solvents were evaporated to dryness in vacuo to give compound 9 (490 mg, 88 %) as a white solid.
5-[(Cholest-5-en-3β-yloxy)methyl]-3-(phenyl)isoxazole (4a):
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3β-[N-(4-Aminobutyl)carbamoyl]cholesterol (9):
3β-(N-{4-[(4-Formylbenzoyl)amino]butyl}carbamoyl)cholesterol (11):
DCC (99 mg, 0.48 mmol, 1.2 equiv.) and DM AP (5 9 m g, 0.48 mmol, 1.2 equiv.) were added to a suspension of aminocarbamate cholesterol 9 (200 mg, 0.40 mmol) and 4-(dimethoxymethyl)-benzoic acid [20] (94 mg, 0.48 mmol, 1.2 equiv.) in dry CH 2 Cl 2 (5 mL) and dry toluene (5 mL) at 0°C under argon. The mixture was stirred at room temperature for 17 h, then the solvent was removed. The residue was purified by flash column chromatography (hexane/EtOAc 35 %) to give 3β-cholest-5-en-3-yl N-{3-[ (4-dimeth A solution of HCl (2 n; 10 mL) was added to a solution of crude protected aldehyde 10 (512 mg) in toluene (10 mL). After a few minutes in a sonication bath, the emulsion was stirred for 2 h at room temp. The reaction was carefully quenched with satd. aqueous NaHCO 3 until the aqueous layer became neutral. 
3β-(N-{4-[(4-Hydroxyiminoformylbenzoyl)amino]butyl}carbamoyl)-cholesterol (12)
Method A Ϫ from Free Aldehyde 11: A mixture of aldehyde 11 (80 mg, 0.13 mmol), hydroxylamine hydrochloride (14 mg, 0.19 mmol, 1.5 equiv.), and pyridine (15 mg, 0.19 mmol, 1.5 equiv.) in EtOH (3 mL) was heated to 125°C for 1 h in a microwave reactor (10 mL vessel, P max = 300 W). The solvent was removed under reduced pressure. The residue was dissolved in chloroform, and this solution was washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure to give oxime 12 (42 mg, 48 %) as an off-white solid.
Method B Ϫ from Protected Aldehyde 10:
A mixture of 10 (80 mg, 0.12 mmol), hydroxylamine hydrochloride (52 mg, 0.71 mmol, 6 equiv.), and pyridine (28 mg, 0.35 mmol, 3 equiv.) in EtOH (3 mL) was heated to 125°C for 1 h in a microwave reactor (10 mL vessel, P max = 300 W). The solvent was removed under reduced pressure. The residue was dissolved in chloroform, and this solution was washed with satd. aq. NaHCO 3 
General Procedure for the Formation of Amidocarbamate-Linked Steroidal Conjugates 14a,b:
The alkyne (1 equiv.), propargyl alcohol (leading to 14a), or phenyl propargyl ether (leading to 14b) was added to a round-bottomed flask containing oxime 12 (2 equiv.) and Ch-T (2.5 equiv.) in EtOH (1 mL per 0.1 mmol oxime). The mixture was stirred for 17 h at room temp. The mixture was extracted with toluene, and the organic phase was washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. The residue was purified by flash column chromatography (hexane/EtOAc 0-15 %) to give the title compounds. 56.7, 56.2, 53.0, 50.1, 42.3, 39.8, 39.5, 38.6, 37.0, 36.6,  36.2, 35.9, 31.9, 28.2, 27.8, 26.5, 24.3, 23.8, 22.7, 22.6, 21.1, 19.3 
3β-[N-(4-{[4-(5-Hydroxymethyl)isoxazol-3-yl]benzoylaminobutyl})-carbamoyl] cholesterol (14a):
General Procedure for the Preparation of Aldehydes 15:
A mixture of cholesterol (1.00 g, 2.59 mmol), 2-, 3-, or 4-(2-hydroxyethoxy)-benzaldehyde (purchased from TCI Europe; 2.15 g, 12.93 mmol, 5 equiv.), and MK-10 (activated at 120°C overnight before use; 2.00 g) in chloroform (5 mL) was heated to 90°C for 8 h in a microwave reactor (10 mL vessel, P max = 300 W). The solvent was removed under reduced pressure, and hexane (20 mL) was added. The catalyst was removed by filtration and washed with hexane. The solvent was evaporated, and the residue was purified by flash column chromatography (hexane/EtOAc 0-10 %) to give the title compounds. -H -H -2-yn-1-yloxy) benzene and Putative Nitrile Oxides 17, derived from 16: (Prop-2-yn-1-yloxy)benzene (16 mg, 0.12 mmol) was put into a round-bottomed flask, a solution of oxime 16 (100 mg, 0.18 mmol, 1.5 equiv.) and Ch-T (54 mg, 0.24 mmol, 2 equiv.) in EtOH (1 mL per 0.1 mmol oxime) was added. The mixture was stirred for 17 h at room temp. The solvent was removed under reduced pressure, the residue was dissolved in toluene, and this solution was washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. The crude reaction product was purified by flash column chromatography (hexane/ EtOAc 0-10 %) to give the title compounds as off-white solids. Method B Ϫ Following a Modified Procedure: (Prop-2-yn-1-yloxy)-benzene (16 mg, 0.12 mmol) was put into a round-bottomed flask, and a solution of oxime p-16 (50 mg, 0.09 mmol, 0.75 equiv.) and Ch-T (27 mg, 0.12 mmol, 1 equiv.) in EtOH (1 mL per 0.1 mmol oxime) was added. The mixture was stirred for 4 h at room temp. The same dose of oxime/Ch-T was added again, and then the mixture was stirred for a further 17 h at room temp. The solvent was removed under reduced pressure, the residue was dissolved in toluene, and this solution was washed with H 2 O. The organic layer was dried with anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. The crude reaction product was purified by flash column chromatography (hexane/EtOAc 0-10 %) to give compound p- 18 (0.75 equiv.), thymidine mono-alkyne 24 (0.75 equiv.), or thymidine bis-alkyne 26 [18] (1.5 equiv.) was put into a round-bottomed flask, and a solution of oxime p-16 and Ch-T (1.5 equiv. for 22 and 24,
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